Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 8.04%6.66T | 19.16%2.25T | -37.88%1.34T | 16.46%2.79T | 205.26%285.14B | -0.31%6.17T | -40.33%1.89T | -21.35%2.15T | 773.75%2.4T | -2,977.16%-270.89B |
Net income from continuing operations | -45.54%1.01T | -101.29%-645.58B | -9.75%496.82B | -29.61%546.22B | -27.67%607.82B | -48.52%1.85T | 54.92%-320.71B | -6.95%550.5B | -56.87%775.97B | -55.93%840.31B |
Operating gains losses | 2,861.94%641.32B | 440.72%591.06B | 120.69%7.08B | -21.10%20.16B | 118.59%23.02B | 94.31%-23.22B | 173.64%109.31B | -141.92%-34.22B | 115.84%25.55B | 31.19%-123.86B |
Depreciation and amortization | 3.64%3.98T | 3.05%1T | 7.51%1.06T | -1.53%921.12B | 5.31%1T | 4.09%3.84T | 0.42%972.88B | 6.03%983.48B | 2.92%935.43B | 7.26%952.87B |
Deferred tax | -59.34%320.95B | -282.76%-171.56B | -30.68%194.51B | -31.75%173.31B | -22.53%124.7B | 71.03%789.37B | 114.02%93.87B | 688.60%280.61B | -52.85%253.93B | -71.11%160.95B |
Other non cash items | -309.83%-678.07B | -663.74%-79.85B | -195.28%-351.52B | -251.14%-122.46B | 11.88%-124.23B | -5.16%323.15B | -94.32%14.17B | 8.43%368.94B | 144.17%81.03B | -115.89%-140.98B |
Change In working capital | 172.58%598.03B | 13.42%739.7B | -134.48%-80.05B | 507.61%1.15T | 15.13%-1.21T | -1,109.32%-823.98B | -78.39%652.18B | -73.20%232.17B | 83.93%-281.89B | 35.11%-1.43T |
-Change in receivables | 222.24%1.16T | 287.70%1.32T | -112.67%-59.65B | 27.43%-347.66B | 119.37%248.29B | -318.01%-949.9B | -48.11%340.53B | -74.74%470.82B | 8.57%-479.09B | 17.85%-1.28T |
-Change in inventory | -30.32%914.74B | 444.58%602.61B | -119.76%-198.9B | 6,042.25%734.11B | -145.19%-223.07B | 772.17%1.31T | -112.35%-174.88B | 12.44%1.01T | 99.30%-12.35B | 166.90%493.6B |
-Change in payables and accrued expense | 24.03%-319.34B | -94.36%42.71B | 115.45%154.69B | 81.93%586.45B | -121.41%-1.1T | -155.76%-420.36B | -52.95%757B | 40.14%-1T | -47.81%322.35B | -348.91%-498.25B |
-Change in other current assets | -225.23%-6.8B | -1,248.06%-254.19B | 463.43%217.08B | -61.87%17.24B | 694.18%13.07B | 102.20%5.43B | 118.59%22.14B | -165.22%-59.73B | 178.08%45.22B | 98.64%-2.2B |
-Change in other current liabilities | -107.18%-938.54B | -370.54%-944.66B | 134.79%19.1B | 123.82%39.64B | -70.31%-52.62B | 12.88%-453B | 57.46%-200.76B | 68.83%-54.91B | -896.62%-166.44B | -121.35%-30.9B |
-Change in other working capital | 33.15%-213.24B | 70.62%-26.98B | -64.63%-212.38B | 1,317.50%119.25B | 12.57%-93.13B | -7.89%-318.96B | -26.20%-91.84B | 4.72%-129.01B | 306.76%8.41B | -27.75%-106.52B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 8.04%6.66T | 19.16%2.25T | -37.88%1.34T | 16.46%2.79T | 205.26%285.14B | -0.31%6.17T | -40.33%1.89T | -21.35%2.15T | 773.75%2.4T | -2,977.16%-270.89B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 39.27%-4.49T | -113.17%-1.75T | 152.90%555.71B | 17.11%-1.8T | 55.40%-1.49T | -75.08%-7.39T | -793.80%-821.31B | 57.99%-1.05T | -145.34%-2.17T | -251.25%-3.34T |
Net PPE purchase and sale | -13.05%-7.63T | 9.59%-1.98T | -17.46%-1.86T | -19.92%-1.94T | -36.21%-1.84T | -36.91%-6.75T | -0.52%-2.18T | -66.12%-1.59T | -67.58%-1.62T | -62.85%-1.35T |
Net intangibles purchase and sale | -6.54%-481.07B | -4.19%-218.39B | -39.71%-111.72B | 3.53%-77.2B | 9.99%-73.77B | 6.92%-451.55B | -77.00%-209.61B | 31.98%-79.97B | 30.70%-80.03B | 38.69%-81.95B |
Net business purchase and sale | 39.69%-256.63B | -250.13%-146.58B | 109.63%28.16B | -558.42%-105.5B | 84.77%-32.71B | 65.96%-425.49B | -16.98%97.64B | -17.02%-292.31B | 98.31%-16.02B | -26.06%-214.79B |
Net investment purchase and sale | 3,613.32%3.73T | -71.65%423.41B | 213.36%2.56T | 154.16%249.11B | 128.26%494.8B | -95.06%100.41B | -34.81%1.49T | 163.87%817.29B | -150.27%-459.92B | -1,782.81%-1.75T |
Net other investing changes | -19.81%151.5B | 1,017.50%168.22B | -164.36%-59.07B | 29.94%78.56B | -165.80%-36.21B | -51.48%188.93B | 4.89%-18.33B | -8.17%91.77B | -73.75%60.46B | -29.82%55.04B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 39.27%-4.49T | -113.17%-1.75T | 152.90%555.71B | 17.11%-1.8T | 55.40%-1.49T | -75.08%-7.39T | -793.80%-821.31B | 57.99%-1.05T | -145.34%-2.17T | -251.25%-3.34T |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1,188.81%-2.3T | -11.07%-1.63T | -522.25%-2.14T | 114.66%127.44B | -46.31%1.35T | -113.54%-178.59B | 37.59%-1.47T | -126.67%-343.92B | -980.79%-869.28B | 1.53%2.51T |
Net issuance payments of debt | -435.93%-2.05T | -26.46%-1.7T | -1,486.19%-2.05T | 228.91%470.29B | -49.44%1.24T | -68.14%609.2B | 41.92%-1.35T | -108.14%-129.38B | -158.31%-364.82B | 21.54%2.45T |
Net common stock issuance | ---92.31B | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash dividends paid | -3.52%-844.2B | 0.90%-189.06B | 2.66%-192.51B | -8.29%-461.89B | -91.15%-734M | 33.07%-815.45B | -25.58%-190.78B | 35.58%-197.77B | 43.82%-426.51B | -26.32%-384M |
Net other financing activities | 1,706.89%681.27B | 290.59%257.8B | 1,419.04%196.92B | 261.24%119.04B | 77.83%107.51B | -94.13%37.7B | -43.70%66B | -239.64%-14.93B | -229.15%-73.83B | -86.77%60.46B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1,188.81%-2.3T | -11.07%-1.63T | -522.25%-2.14T | 114.66%127.44B | -46.31%1.35T | -113.54%-178.59B | 37.59%-1.47T | -126.67%-343.92B | -980.79%-869.28B | 1.53%2.51T |
Net cash flow | ||||||||||
Beginning cash position | -17.17%6.67T | 8.14%7.73T | 26.52%8.03T | -1.93%6.87T | -17.17%6.67T | 68.63%8.05T | -4.65%7.15T | 10.05%6.35T | 10.73%7.01T | 68.63%8.05T |
Current changes in cash | 91.08%-124.86B | -180.33%-1.14T | -132.39%-246.12B | 273.51%1.12T | 112.52%138.83B | -142.57%-1.4T | -143.84%-405.16B | -50.26%759.83B | 6.76%-644.46B | -172.70%-1.11T |
Effect of exchange rate changes | 1,227.11%221.88B | 346.26%174.75B | -260.34%-59.37B | 391.53%42.61B | -2.11%63.89B | 291.29%16.72B | 80.65%-70.96B | -81.33%37.03B | -111.15%-14.62B | 129.65%65.27B |
End cash Position | 1.45%6.77T | 1.45%6.77T | 8.14%7.73T | 26.52%8.03T | -1.93%6.87T | -17.17%6.67T | -17.17%6.67T | -4.65%7.15T | 10.05%6.35T | 10.73%7.01T |
Free cash flow | -41.48%-1.5T | 106.68%34.02B | -232.40%-641.87B | 8.24%744.88B | 5.08%-1.64T | -238.24%-1.06T | -158.75%-508.98B | -70.89%484.8B | 184.89%688.19B | -80.47%-1.72T |
Currency Unit | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |